Abstract

Application of Sildenafil for Pulmonary Hypertension in Canines and Foals

Author(s): Davidson Gigi S

Issue: Nov/Dec 2006 - Veterinary Compounding

Page(s): 405-408

Download in electronic PDF format for $75

Abstract

Pulmonary arterial hypertension is the most commonly recognized form of pulmonary hypertension in canines. Persistent pulmonary hypertension is a life-threatening condition in neonatal foals. Treatment of pulmonary hypertension in both canines and neonatal foals has focused on the correction of hypoxia and acidosis, not on the pulmonary hypertension itself. Identification of pulmonary hypertension in canines and foals has been made easier with the new diagnostic technologies that are being employed by veterinarians. Although retrospective reviews and studies have been published on the use of sildafenil, which is used primarily for the treatment of human erectile dysfunction, to treat pulmonary hypertension in human neonates, and the pharmacodynamics of sildenafil have been examined in various species, sildenafil has not been used widely in dogs or foals. Therefore, the adverse effects of sildafenil in canines and foals have not been determined. Until the stability of sildenafil in suspension has been determin

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2006 Pg. 405-408	Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Author(s): Davidson Gigi S
Jan/Feb 2013 Pg. 24-27	Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Author(s): Wung Deanna
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jul/Aug 1997 Pg. 242-243	Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Jul/Aug 2006 Pg. 306	Sildenafil Citrate 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 230	Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Jan/Feb 2005 Pg. 70	Tolazoline Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Jan/Feb 2003 Pg. 27-29	Equine Cushing’s Syndrome Author(s): Vail Jane
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Jan/Feb 2001 Pg. 55-57	Rhodococcus Equi Pneumonia in Foals Author(s): Davidson Gigi S
Mar/Apr 2001 Pg. 92-94	Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension Author(s): Davidson Michael G
Mar/Apr 2005 Pg. 153	Sildenafil 1% Vaginal Cream or Gel Author(s): Allen Loyd V Jr